HLA-D antigens

Preferred Label : HLA-D antigens;

MeSH definition : Human immune-response or Class II antigens found mainly, but not exclusively, on B-lymphocytes and produced from genes of the HLA-D locus. They are extremely polymorphic families of glycopeptides, each consisting of two chains, alpha and beta. This group of antigens includes the -DR, -DQ and -DP designations, of which HLA-DR is most studied; some of these glycoproteins are associated with certain diseases, possibly of immune etiology.;

MeSH synonym : antigens, human immune-response; hla-dw; immune response antigens, human; hla dw antigens; hla-d; hla-dw antigens; human class ii antigens; human ia-like antigens; human immune-associated antigens; human immune-response antigens; ia like antigens, human; ia-like antigens, human; immune associated antigens, human; immune response associated antigens, human; immune response-associated antigens, human; immune-associated antigens, human; immune-response antigens, human; antigens, hla d; antigens, hla-d; antigens, hla-dw; antigens, human ia-like; antigens, human immune-associated; class ii human antigens; HLA D antigens;

MeSH annotation : general; prefer specifics;

Is substance : O;

Details

Origin ID

D006681;

UMLS CUI

C0019754;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- HLA Ag [LOINC component]
- HLA-DQ [LOINC component]
- HLA-DR [LOINC component]
- HLA-DR Ag [LOINC component]
- HLA-DR Antigen [NCIt concept]
- HLA-DR+ cells [LOINC component]
- Human leukocyte antigen DR (substance) [SNOMED CT concept]
- Human leukocyte antigen complex [FMA entity]
- hla antigen present [SNOMED Notion]
- hla antigen, nos [SNOMED Notion]
- hla-a antigen, nos [SNOMED Notion]
- hla-b antigen, nos [SNOMED Notion]
- hla-c antigen, nos [SNOMED Notion]
- hla-dr antigen, nos [SNOMED Notion]
Currated CISMeF NLP mapping
- HLA-D [LOINC hierarchical part]
- Human leukocyte antigen D (substance) [SNOMED CT concept]
- hla-d antigen, nos [SNOMED Notion]
- hla-dw antigen, nos [SNOMED Notion]
Record concept(s)
- HLA-D antigens [MeSH concept]
Related MeSH Supplementary Concept(s)
- E(S)(beta) peptide [MeSH Supplementary Concept]
- HLA te antigen [MeSH Supplementary Concept]
- HLA-DM antigens [MeSH Supplementary Concept]
- HLA-DN antigens [MeSH Supplementary Concept]
- HLA-DO antigens [MeSH Supplementary Concept]
- HLA-DW14.1 antigen [MeSH Supplementary Concept]
- HLA-Dw12 antigens [MeSH Supplementary Concept]
- HLA-Dw14 antigen [MeSH Supplementary Concept]
- HLA-Dw15 [MeSH Supplementary Concept]
- HLA-Dw19 antigen [MeSH Supplementary Concept]
- HLA-Dw4 antigen [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
UMLS correspondences (same concept)
- HLA-D [LOINC hierarchical part]
- Human leukocyte antigen D (substance) [SNOMED CT concept]
- hla-d antigen, nos [SNOMED Notion]
- hla-dw antigen, nos [SNOMED Notion]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients